Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected Patients

NCT00001357 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

NIH

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Interleukin-2

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)